Related Experiment Video
Updated: Oct 22, 2025

08:35
Elastomeric PGS Scaffolds in Arterial Tissue Engineering
Published on: April 8, 2011
15.8K
PGS/HAp Microporous Composite Scaffold Obtained in the TIPS-TCL-SL Method: An Innovation for Bone Tissue Engineering
Paweł Piszko1, Marcin Włodarczyk2, Sonia Zielińska1
1Department of Polymer Engineering and Technology, Faculty of Chemistry, Wrocław University of Science and Technology (WUST), Wyb. Wyspiańskiego 27, 50-370 Wrocław, Poland.
International Journal of Molecular Sciences
|August 27, 2021
Summary
This study developed a poly(glycerol sebacate) (PGS) composite with nano-hydroxyapatite (HAp) for bone tissue engineering. The PGS/HAp scaffolds demonstrated excellent biocompatibility, osteoconductivity, and promoted bone regeneration.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Nanotechnology
Background:
- Poly(glycerol sebacate) (PGS) is a promising biodegradable elastomer for biomedical applications.
- Nano-hydroxyapatite (HAp) is a key component in bone tissue, known for its osteoconductive properties.
- Developing advanced composite scaffolds is crucial for effective bone regeneration.
Purpose of the Study:
- To synthesize and characterize a novel PGS-based composite incorporating nano-hydroxyapatite (HAp).
- To evaluate the structural, mechanical, and biological properties of the microporous PGS/HAp scaffolds.
- To assess the potential of these scaffolds for bone tissue engineering applications.
Main Methods:
- Poly(glycerol sebacate) pre-polymer (pPGS) and nano-hydroxyapatite (HAp) were synthesized and characterized.
- Microporous PGS/HAp composites were fabricated using thermally induced phase separation (TIPS), thermal cross-linking (TCL), and salt leaching (SL).
- Scaffold characterization involved SEM, µCT, DSC, TGA, water contact angle, and in vitro cell studies with osteoblasts.
Main Results:
- The PGS/HAp composite scaffolds exhibited a well-defined microporous structure.
- In vitro studies confirmed excellent cytocompatibility, cell adhesion, and osteogenic differentiation of hFOB 1.19 cells on the scaffolds.
- PGS/HAp scaffolds significantly induced osteoclastogenic cytokines (IL-1β, IL-6, TNF-α), promoting bone remodeling and reconstruction.
Conclusions:
- The developed PGS/HAp composite scaffolds are biocompatible and osteoconductive, showing great potential for bone regeneration.
- The HAp addition enhances the osteogenic properties of PGS scaffolds, facilitating bone tissue reconstruction.
- These findings support the use of PGS/HAp composites as advanced biomaterials for orthopedic applications.

